Fader AN - Search Results

1

The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches.

Nasioudis D, Fernandez ML, Wong N, Powell DJ Jr, Mills GB, Westin S, Fader AN, Carey MS, Simpkins F. Nasioudis D, et al. Among authors: fader an. Gynecol Oncol. 2023 Oct;177:86-94. doi: 10.1016/j.ygyno.2023.08.007. Epub 2023 Aug 30. Gynecol Oncol. 2023. PMID: 37657193

2

Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review.

Boruta DM 2nd, Gehrig PA, Fader AN, Olawaiye AB. Boruta DM 2nd, et al. Among authors: fader an. Gynecol Oncol. 2009 Oct;115(1):142-153. doi: 10.1016/j.ygyno.2009.06.011. Epub 2009 Jul 9. Gynecol Oncol. 2009. PMID: 19592079 Review.

3

Hormone replacement therapy in gynecologic cancer survivors: why not?

Ibeanu O, Modesitt SC, Ducie J, von Gruenigen V, Agueh M, Fader AN. Ibeanu O, et al. Among authors: fader an. Gynecol Oncol. 2011 Aug;122(2):447-54. doi: 10.1016/j.ygyno.2011.03.012. Epub 2011 Apr 6. Gynecol Oncol. 2011. PMID: 21474167 Review.

4

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

Coleman RL, Sill MW, Lankes HA, Fader AN, Finkler NJ, Hoffman JS, Rose PG, Sutton GP, Drescher CW, McMeekin DS, Hu W, Deavers M, Godwin AK, Alpaugh RK, Sood AK. Coleman RL, et al. Among authors: fader an. Gynecol Oncol. 2012 Dec;127(3):538-43. doi: 10.1016/j.ygyno.2012.08.020. Epub 2012 Aug 23. Gynecol Oncol. 2012. PMID: 22922531 Free PMC article. Clinical Trial.

5

Laparoendoscopic single-site surgery (LESS) radical hysterectomy for the treatment of early stage cervical cancer.

Tergas AI, Fader AN. Tergas AI, et al. Among authors: fader an. Gynecol Oncol. 2013 Apr;129(1):241-3. doi: 10.1016/j.ygyno.2012.12.025. Epub 2012 Dec 20. Gynecol Oncol. 2013. PMID: 23262206

6

Early stage uterine serous carcinoma: management updates and genomic advances.

Fader AN, Santin AD, Gehrig PA. Fader AN, et al. Gynecol Oncol. 2013 Apr;129(1):244-50. doi: 10.1016/j.ygyno.2013.01.004. Epub 2013 Jan 12. Gynecol Oncol. 2013. PMID: 23321062 Review.

7

Cost analysis of colposcopy for abnormal cytology in post-treatment surveillance for cervical cancer.

Tergas AI, Havrilesky LJ, Fader AN, Guntupalli SR, Huh WK, Massad LS, Rimel BJ. Tergas AI, et al. Among authors: fader an. Gynecol Oncol. 2013 Sep;130(3):421-5. doi: 10.1016/j.ygyno.2013.05.037. Epub 2013 Jun 5. Gynecol Oncol. 2013. PMID: 23747836

8

Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?

Ricci S, Giuntoli RL 2nd, Eisenhauer E, Lopez MA, Krill L, Tanner EJ 3rd, Gehrig PA, Havrilesky LJ, Secord AA, Levinson K, Frasure H, Celano P, Fader AN. Ricci S, et al. Among authors: fader an. Gynecol Oncol. 2013 Dec;131(3):629-33. doi: 10.1016/j.ygyno.2013.08.037. Epub 2013 Sep 7. Gynecol Oncol. 2013. PMID: 24016408

9

High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes.

Doll KM, Tseng J, Denslow SA, Fader AN, Gehrig PA. Doll KM, et al. Among authors: fader an. Gynecol Oncol. 2014 Jan;132(1):44-9. doi: 10.1016/j.ygyno.2013.10.023. Epub 2013 Oct 29. Gynecol Oncol. 2014. PMID: 24183734

10

Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy.

Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. Gunderson CC, et al. Among authors: fader an. Gynecol Oncol. 2014 Jan;132(1):33-7. doi: 10.1016/j.ygyno.2013.11.033. Epub 2013 Dec 4. Gynecol Oncol. 2014. PMID: 24316307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page